Table 3 Comparison of average hospital length of stay (in days) per patient by post-therapy complications status among cancer patients.
Therapy and cancer group | Per-patient mean hospital LOS (SD) | |||
|---|---|---|---|---|
No post-therapy complications | Diagnosed at least post-therapy complications | Mean difference | ||
Mean LOS in days (SD) | Mean LOS in days (SD) | Mean difference of LOS in days (95% CI)§ | p-value | |
Type of therapy | ||||
Systemic therapy | 6.12 (10.63) | 369.71 (1060.25) | 363.6 (330.51 to 396.68) | < 0.001 |
Radiation therapy | 10.12 (19.55) | 108.88 (219.48) | 98.77 (71.46 to 126.07) | < 0.001 |
Systemic therapy and radiotherapy | 19.87 (17.96) | 373.66 (783.4) | 353.8 (248.76 to 458.84) | < 0.001 |
Cancer group | ||||
Oral | na | 311.15 (483.74) | - | - |
Bladder | 6.07 (13.58) | 323.3 (771.92) | 317.24 (244.74 to 389.73) | < 0.001 |
Pancreatic cancer | na | 63.27 (87.87) | - | - |
Brain | 8.09 (14.63) | 57.11 (70.19) | 49.02 (22.56 to 75.48) | < 0.001 |
Cervical cancer | 6.1 (12.18) | 262.5 (414.13) | 256.4 (−29.99 to 542.79) | 0.087 |
Stomach cancer | 7.56 (6.86) | 110.12 (141.72) | 102.56 (74.46 to 130.66) | < 0.001 |
Esophageal cancer | 2.99 (3.18) | 144.44 (196.98) | 141.45 (67.62 to 215.28) | < 0.001 |
Gastric Cardia | 8.03 (11.44) | 191.45 (412.42) | 183.42 (122.76 to 244.09) | < 0.001 |
Colorectal cancer | 5.31 (13.61) | 105.13 (115.79) | 99.82 (49.68 to 149.97) | < 0.001 |
Hodgkin lymphoma | 3.42 (4.89) | 340.38 (929.59) | 336.95 (244.8 to 429.1) | < 0.001 |
Non-Hodgkin lymphoma | 4.85 (10.46) | 448.94 (1075.73) | 444.09 (381.83 to 506.36) | < 0.001 |
Multiple myeloma | 5.08 (8.95) | 812.86 (1452.64) | 807.78 (688.87 to 926.69) | < 0.001 |
Anal canal | 6.61 (9.45) | 208.76 (494.82) | 202.16 (169.89 to 234.43) | < 0.001 |
Liver | 6.71 (11.44) | 127.08 (260.18) | 120.37 (71.29 to 169.44) | < 0.001 |
Melanoma of the skin | 6.06 (12.39) | 235.67 (688.49) | 229.61 (127.77 to 331.45) | < 0.001 |
Pancreas | 8.21 (12.56) | 100.62 (129.28) | 92.41 (73.05 to 111.76) | < 0.001 |
Lung | 8.23 (13.94) | 114.44 (212.59) | 106.21 (92.86 to 119.56) | < 0.001 |
Breast | 5.93 (10.28) | 99.48 (244.21) | 93.55 (70.89 to 116.22) | < 0.001 |
Ovary | 1.84 (1.57) | 239.66 (405.98) | 237.82 (76.54 to 399.11) | < 0.001 |
Kidney | 3.7 (2.99) | 257.76 (516.34) | 254.06 (88.38 to 419.75) | < 0.001 |
Thyroid | 4.62 (6.91) | 184.55 (467.05) | 179.93 (−17.85 to 377.71) | 0.076 |
III-defined sites | na | na | - | - |
Unspecified malignant neoplasm | 7.75 (9.81) | 130.49 (256.45) | 122.73 (102.31 to 143.15) | < 0.001 |
Rectal cancer | 10.7 (14.12) | 134.23 (202.2) | 123.53 (56.63 to 190.43) | < 0.001 |
Bone and bone marrow | 8.75 (12.04) | 173.28 (323.06) | 164.53 (125.09 to 203.96) | < 0.001 |
Acute lymphoblastic leukemia | 5.05 (7.89) | 946.04 (21.37) | 940.99 (760.89 to 1121.09) | < 0.001 |
Others | 7.59 (15.58) | 253.49 (669.49) | 245.91 (194.99 to 296.83) | < 0.001 |
Overall | 6.48 (11.52) | 360.12 (1029.53) | 353.65 (336.28 to 371.02) | < 0.001 |
